The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in

Laura Hruby1, Katerina Schaal2, Alberto Delaidelli3,4,5

  • 1Institute of Neuropathology, University Hospital Düsseldorf and Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Cell Death Discovery
|July 16, 2025
PubMed

Insights

MYC drives aggressive medulloblastoma (MB) by increasing eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1). High EIF4EBP1 levels correlate with poor prognosis in MB patients, indicating its role in tumor aggressiveness.

Area of Science:

  • Pediatric neuro-oncology
  • Cancer molecular biology
  • Translational research

Background:

  • Medulloblastoma (MB) is the most common malignant pediatric brain tumor.
  • Group 3 MB has the poorest prognosis, with poorly understood drivers of aggressiveness.
  • Eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1) is implicated but its role is unclear.

Purpose of the Study:

  • To investigate the prognostic role of EIF4EBP1 in MB.
  • To elucidate the mechanisms driving EIF4EBP1 overexpression in Group 3 MB.
  • To assess the functional impact of EIF4EBP1 on MB cell tumorigenicity.

Main Methods:

  • Analysis of publicly available EIF4EBP1 mRNA expression datasets.
  • Correlation analysis with MYC expression and patient survival data.
  • Immunohistochemistry for 4EBP1 protein.
  • Functional assays for MB cell colony formation and promoter activity.

Main Results:

  • EIF4EBP1 mRNA is upregulated in MB and higher in Group 3 vs. Group 4.
  • High EIF4EBP1 expression correlates with reduced overall and event-free survival.
  • MYC directly regulates EIF4EBP1 transcription, explaining overexpression in Group 3.
  • 4EBP1 supports in vitro MB cell colony formation.

Conclusions:

  • Transcriptional upregulation of EIF4EBP1 by MYC contributes to MB aggressiveness.
  • EIF4EBP1 is a potential therapeutic target for high-risk medulloblastoma.
  • High EIF4EBP1 expression is a marker of poor prognosis in MB patients.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K